|
| 37036681 | Targeted Transcriptional Analysis of IgA Vasculitis, IgA Nephropathy, and IgA-Dominant Infection-Related Glomerulonephritis Reveals Both Distinct and Overlapping Immune Signatures. | Kidney360 | 2023 |
| 37668330 | Intraosseous Spindle Cell Rhabdomyosarcoma with <i>MEIS1</i>::<i>NCOA2</i> Fusion - Case Report with Substantial Clinical Follow-up and Review of the Literature. | Cancer Invest | 2023 |
| 37890277 | Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor. | J Clin Oncol | 2023 |
| 37410972 | Activity of Type II RAF Inhibitor Tovorafenib in a Pediatric Patient With a Recurrent Spindle Cell Sarcoma Harboring a Novel <i>SNX8-BRAF</i> Gene Fusion. | JCO Precis Oncol | 2023 |
| 34426440 | Establishment of Patient-Derived Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response. | Clin Cancer Res | 2022 |
| 35382931 | Neoadjuvant tyrosine kinase inhibitor therapy for patients with gastrointestinal stromal tumor: A propensity-matched analysis. | Am J Surg | 2022 |
| 35829795 | Ten-Year Survivorship in Patients with Metastatic Gastrointestinal Stromal Tumors. | Ann Surg Oncol | 2022 |
| 35692807 | Single-Cell Proteomics Analysis of Recurrent Low-Grade Serous Ovarian Carcinoma and Associated Brain Metastases. | Front Oncol | 2022 |
| 35483883 | Corrigendum: Functional impact and targetability of <i>PI3KCA</i>, <i>GNAS</i>, and <i>PTEN</i> mutations in a spindle cell rhabdomyosarcoma with MYOD1 L122R mutation. | Cold Spring Harb Mol Case Stud | 2022 |
| 35904656 | ASO Visual Abstract: Ten-Year Survivorship in Patients with Metastatic Gastrointestinal Stromal Tumors. | Ann Surg Oncol | 2022 |
| 36134040 | Biclonal Desmoid-Type Fibromatosis With Two Beta-Catenin Mutations: Evidence for the Recruitment of Normal Myofibroblasts. | Cureus | 2022 |
| 34924291 | Hepatic metastases in gastrointestinal stromal tumors: oncologic outcomes with curative-intent hepatectomy, resection of treatment-resistant disease, and tyrosine kinase inhibitor therapy alone. | HPB (Oxford) | 2022 |
| 33296093 | Post-treatment hypermutation in a recurrent diffuse glioma with H3.3 p.G34 Mutation. | Neuropathol Appl Neurobiol | 2021 |
| 33850302 | Novel BRAF gene fusions and activating point mutations in spindle cell sarcomas with histologic overlap with infantile fibrosarcoma. | Mod Pathol | 2021 |
| 33797935 | Inhibition of KIT Tyrosine Kinase Activity: Two Decades After the First Approval. | J Clin Oncol | 2021 |
| 33772089 | Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics. | NPJ Precis Oncol | 2021 |
| 34667258 | Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapies. | NPJ Precis Oncol | 2021 |
| 34429303 | Mechanisms of targeted therapy resistance in a pediatric glioma driven by <i>ETV6-NTRK3</i> fusion. | Cold Spring Harb Mol Case Stud | 2021 |
| 33969462 | Disease-free Interval Is Associated with Oncologic Outcomes in Patients with Recurrent Gastrointestinal Stromal Tumor. | Ann Surg Oncol | 2021 |
| 34250408 | Exceptional Response to Trastuzumab in a Heavily Pretreated Patient With ERBB3-Mutated Metastatic Breast Cancer. | JCO Precis Oncol | 2021 |
| 34326133 | Location of Gastrointestinal Stromal Tumor (GIST) in the Stomach Predicts Tumor Mutation Profile and Drug Sensitivity. | Clin Cancer Res | 2021 |
| 34036664 | GAB1-ABL1 fusions in tumors that have histologic overlap with NTRK-rearranged spindle cell tumors. | Genes Chromosomes Cancer | 2021 |
| 34090672 | Imatinib-resistant gastrointestinal stromal tumors in the era of second- and third-line tyrosine kinase inhibitors: Does surgical resection have a role? | Surgery | 2021 |
| 33109560 | Evaluation of an Assay for MGMT Gene Promoter Methylation in Glioblastoma Samples. | Anticancer Res | 2020 |
| 34541020 | Predicting primary site of secondary liver cancer with a neural estimator of metastatic origin. | J Med Imaging (Bellingham) | 2020 |
| 31994201 | Recurrent RET gene fusions in paediatric spindle mesenchymal neoplasms. | Histopathology | 2020 |
| 31837433 | Multi-Institutional Evaluation of Interrater Agreement of Variant Classification Based on the 2017 Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer. | J Mol Diagn | 2020 |
| 31739757 | Low-grade Osteosarcomatous Dedifferentiation of an Atypical Lipomatous Tumor in a Pediatric Patient. | Pediatr Dev Pathol | 2020 |
| 31792356 | NTRK gene rearrangements are highly enriched in MLH1/PMS2 deficient, BRAF wild-type colorectal carcinomas-a study of 4569 cases. | Mod Pathol | 2020 |
| 33060677 | SHIFT: speedy histological-to-immunofluorescent translation of a tumor signature enabled by deep learning. | Sci Rep | 2020 |
| 29691710 | Colorectal Cancer-Associated Spontaneous Tumor Lysis Syndrome: a Case Report and Review of the Current Literature. | J Gastrointest Cancer | 2019 |
| 31435988 | A case of recurrent epilepsy-associated rosette-forming glioneuronal tumor with anaplastic transformation in the absence of therapy. | Neuropathology | 2019 |
| 31362756 | Loss of the PTCH1 tumor suppressor defines a new subset of plexiform fibromyxoma. | J Transl Med | 2019 |
| 30867899 | Genomic aberrations in cell cycle genes predict progression of KIT-mutant gastrointestinal stromal tumors (GISTs). | Clin Sarcoma Res | 2019 |
| 30833418 | Circulating tumor DNA dynamics using patient-customized assays are associated with outcome in neoadjuvantly treated breast cancer. | Cold Spring Harb Mol Case Stud | 2019 |
| 28744009 | Efficacy and safety of midostaurin in patients with advanced systemic mastocytosis: 10-year median follow-up of a phase II trial. | Leukemia | 2018 |
| 30551737 | Implementing a comprehensive translational oncology platform: from molecular testing to actionability. | J Transl Med | 2018 |
| 28644569 | Gastrointestinal stromal tumours of the oesophagus: a clinicopathological and molecular analysis of 27 cases. | Histopathology | 2017 |
| 31650098 | Molecular Testing in Patients With Castration-Resistant Prostate Cancer and Its Impact on Clinical Decision Making. | JCO Precis Oncol | 2017 |
| 30364881 | BREAST CANCER HISTOPATHOLOGY IMAGE ANALYSIS PIPELINE FOR TUMOR PURITY ESTIMATION. | Proc IEEE Int Symp Biomed Imaging | 2017 |
| 28196207 | Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033. | JAMA Oncol | 2017 |
| 28334361 | Defining the Impact of Adjuvant Therapy in Molecularly Defined Subsets of Gastrointestinal Stromal Tumor : From Lumping to Splitting. | JAMA Oncol | 2017 |
| 28270683 | MAX inactivation is an early event in GIST development that regulates p16 and cell proliferation. | Nat Commun | 2017 |
| 28266931 | Biliary Adenofibroma of Liver: Morphology, Tumor Genetics, and Outcomes in 6 Cases. | Am J Surg Pathol | 2017 |
| 28502724 | Durable Response to Afatinib in Lung Adenocarcinoma Harboring NRG1 Gene Fusions. | J Thorac Oncol | 2017 |
| 28341590 | Guidelines for Validation of Next-Generation Sequencing-Based Oncology Panels: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists. | J Mol Diagn | 2017 |
| 28317407 | Using molecular diagnostic testing to personalize the treatment of patients with gastrointestinal stromal tumors. | Expert Rev Mol Diagn | 2017 |
| 28724664 | Biochemical, Molecular, and Clinical Characterization of Succinate Dehydrogenase Subunit A Variants of Unknown Significance. | Clin Cancer Res | 2017 |
| 26747586 | A Multiplexed Amplicon Approach for Detecting Gene Fusions by Next-Generation Sequencing. | J Mol Diagn | 2016 |
| 26362343 | Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity. | Urol Oncol | 2016 |